Parkside Financial Bank & Trust’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Parkside Financial Bank & Trust's IONS Position: Q2 2026 in Review
Parkside Financial Bank & Trust reduced its Ionis Pharmaceuticals (IONS) stake by 1.6% in Q2 2026, selling an estimated $301 and leaving 254 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1386.
Parkside Financial Bank & Trust first reported a position in IONS in Q3 2020 and has held it in 22 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- Parkside Financial Bank & Trust held 254 shares of Ionis Pharmaceuticals worth $20.1K as of Q2 2026.
- Parkside Financial Bank & Trust sold 4 Ionis Pharmaceuticals shares in Q2 2026, an estimated $301.
- Ionis Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1386 holding.
- Parkside Financial Bank & Trust first reported a position in Ionis Pharmaceuticals in Q3 2020 and has held it in 22 quarters since.
- 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.